Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?
Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5
Can microvascular damage predict disease severity in patients with systemic sclerosis?
Ana Martins; Sofia Pimenta; Daniela Oliveira; Raquel Miriam Ferreira; Miguel Bernardes; Lúcia Costa; Georgina Terroso;
Reumatol Clin. 2024;20:366-71
Investigating potential biomarkers and therapeutic targets for patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) through the utilization of cytokine profiling
Akhil Akhil; Rohit Bansal; Jyotsana Kaushal; Aman Sharma; Archana Bhatnagar;
Reumatol Clin. 2025;21: